Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Works matching IS 02613360 AND DT 2013 AND VI 32 AND IP 3
Results: 32
1
2
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
3
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
4
Joint hypermobility is a risk factor for musculoskeletal pain during adolescence: findings of a prospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
5
HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 3, p. 109
- By:
- Publication type:
- Article
6
Pulmonary function tests in idiopathic inflammatory myopathy: association with clinical parameters in children.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
7
Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
8
Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
9
Psychiatric illness of systemic lupus erythematosus in childhood: spectrum of clinically important manifestations.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
10
Long-term follow-up in lupus nephritis patients treated with rituximab - clinical and histopathological response.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
11
Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
12
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
13
In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
14
Effect of belimumab treatment on renal outcomes: results from the Phase 3 belimumab clinical trials in patients with SLE.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
15
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
16
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
17
Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
18
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
19
The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
20
Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
21
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
22
A non-inferiority trial of an attenuated combination strategy ("COBRA-light") compared to the original COBRA strategy: clinical results after 26 weeks.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
23
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled Phase 4 trial.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
24
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
25
Enteric-coated mycophenolate sodium for progressive systemic sclerosis - a prospective open-label study with CT histography for monitoring of pulmonary fibrosis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
26
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
27
Leflunomide in psoriatic arthritis: results from a large European prospective observational study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
28
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
29
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
30
Low serum levels of vitamin D in idiopathic inflammatory myopathies.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
31
Disease-Modifying Antirheumatic Drugs or Biological Blockers in Psoriatic Arthritis?
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 3, p. 77
- By:
- Publication type:
- Article
32
Foreword.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 3, p. 77
- By:
- Publication type:
- Article